Published literature and guidelines in thoracic oncology: what is worth reading?

M. Paesmans (Brussels, Belgium)

Source: Annual Congress 2012 - Good quality clinical recommendations for thoracic malignancy management in Europe
Disease area: Thoracic oncology

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Paesmans (Brussels, Belgium). Published literature and guidelines in thoracic oncology: what is worth reading?. Annual Congress 2012 - Good quality clinical recommendations for thoracic malignancy management in Europe

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Proposed new pulmonary hypertension definition: is 4 mm(Hg) worth re-writing medical textbooks?
Source: Eur Respir J, 53 (3) 1900197; 10.1183/13993003.00197-2019
Year: 2019



Challenges and controversies in thoracic oncology: a new ERJ series
Source: Eur Respir J 2014; 43: 1571-1572
Year: 2014


Expanding the spectrum of European Respiratory Society official scientific documents: short documents complement clinical practice guidelines, statements and technical standards
Source: Eur Respir J, 55 (6) 2001030; 10.1183/13993003.01030-2020
Year: 2020



Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology
Source: Breathe 2016; 12: 249-255
Year: 2016


The best papers in the ERJ: clinical practice
Source: Virtual Congress 2021 – The best of the European Respiratory Journal 2021
Year: 2021


Cough clinical practice guidelines: A critical review of scientific evidence and recommendations
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016


Thoracic oncology, this journal club will explore a major randomised trial in mesothelioma treatment, implications for practice and the strengths and weaknesses of the study in the context of the published data
Source: Journal Club 2022
Year: 2022

Improving tumour documentation in thoracic oncology: what can we learn from each other?
Source: Annual Congress 2012 - Good quality clinical recommendations for thoracic malignancy management in Europe
Year: 2012


Cochrane review update leaves big questions unanswered regarding vaping: implications for medical practitioners
Source: Eur Respir J, 57 (5) 2100022; 10.1183/13993003.00022-2021
Year: 2021



National and local care in thoracic oncology: does Europe speak the same language?
Source: Annual Congress 2012 - Good quality clinical recommendations for thoracic malignancy management in Europe
Year: 2012


Current practice: safety checklists for pleural procedures
Source: International Congress 2017 – Pleural interventions and transthoracic ultrasound (TUS)
Year: 2017


Multidisciplinary questions in thoracic oncology: the team experience
Source: Eur Respir J 2016; 48: 626-627
Year: 2016


COVID-19 and COPD: a narrative review of the basic science and clinical outcomes
Source: Eur Respir Rev, 29 (158) 200199; 10.1183/16000617.0199-2020
Year: 2020



Quality management in thoracic oncology: how do patients and clinicians benefit?
Source: Annual Congress 2012 - Good quality clinical recommendations for thoracic malignancy management in Europe
Year: 2012


Reviewing recent research on peer review: myths and reality
Source: Annual Congress 2011 - BMJ/ERJ Symposium – Peer reviewing
Year: 2011

Current evidence for COVID-19 therapies: a systematic literature review
Source: Eur Respir Rev, 30 (159) 200384; 10.1183/16000617.0384-2020
Year: 2021



The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline
Source: Eur Respir Rev, 30 (162) 210171; 10.1183/16000617.0171-2021
Year: 2021